Sur, D., A. Havasi, C. Lungulescu, S. Volovat, C. Burz, and A. Irimie. “Endoglin (CD105) As a Putative Prognostic Biomarker for Colorectal Cancer: A Systematic Review”. Medicine and Pharmacy Reports, Vol. 95, no. 3, May 2022, pp. 251-9, doi:10.15386/mpr-2120.